Back to top

Analyst Blog

On Jul 11, 2013, the shares of Humana Inc. (HUM - Analyst Report) reached a new 52-week high of $86.50. The momentum was driven by the company’s fundamental strength, including higher earnings and Medicare coverage, strong financials, sturdy ratings and an efficient inorganic growth strategy.

Humana has maintained a strong cash and short-term investment position over the past several years. The strong cash position enabled the company to increase its quarterly dividend by 3.85% in Apr 2013, after a 4% dividend hike in Apr 2012.

Moreover, Humana’s individual Medicare stand-alone prescription drugs plan membership has been increasing over the past few years, driven by strategic alliances and competitive pricing. It grew 17.5% in 2012 and 8.9% in the first quarter of 2013. For 2013, the company expects it to increase by 170,000–190,000.

This membership increase should boost Humana’s revenues from the Medicare business, which contributed 72% of the total premiums and service revenues in 2012. The company’s strong earnings and membership growth in the first quarter prompted management to increase the earnings guidance for 2013 to $8.40–$8.60 per share from $7.60–$7.80.

Humana expects its second-quarter earnings in the range of $2.40–$2.50 per share. The Zacks Consensus Estimate for Humana’s second-quarter 2013 earnings stands at $2.46, which is within the company’s guidance range. This translates into a year-over-year increase of 5.03%.

Moreover, the valuation of Humana looks attractive. The shares are trading at a discount to its peers both on a price-to-book and on a forward price-to-earnings basis, while the return on equity of 15.9% is higher than the peer group average of 12.5%. The year-to-date return from the stock is 25.6%, above S&P’s return of 17.4%.

Humana currently carries a Zacks Rank #3 (Hold). Other health maintenance organizations worth considering are Molina Healthcare Inc. (MOH - Analyst Report) – Zacks Rank #1 (Strong Buy), Aetna Inc. (AET - Analyst Report) – Zacks Rank #2 (Buy) and WellPoint Inc. (WLP - Analyst Report) – Zacks Rank #2 (Buy).

Please login to or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research


Are you a new Zacks Member or a visitor to

Top Zacks Features

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
PLANAR SYST… PLNR 4.44 +5.21%
BITAUTO HOL… BITA 81.71 +5.12%
CTPARTNERS… CTP 16.66 +4.26%
CHINA BIOLO… CBPO 47.91 +3.30%
MALLINCKROD… MNK 72.94 +2.85%